SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001104659-24-052918
Filing Date
2024-04-26
Accepted
2024-04-26 16:06:19
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFM14A tm247409-4_defm14a.htm DEFM14A 4290759
2 GRAPHIC lg_inhibrx-pn.jpg GRAPHIC 15684
3 GRAPHIC px_inhibrxspecial01-4c.jpg GRAPHIC 360655
4 GRAPHIC px_inhibrxspecial02-4c.jpg GRAPHIC 213012
  Complete submission text file 0001104659-24-052918.txt   5044992
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-39452 | Film No.: 24883606
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)